Bluepharma to invest EUR 200m to expand and double production
|
06 FEB 2021
|
Intel ID : 316895
|
||||
| Intel ID | 316895 | ||
| Value | EUR 200,00m | ||
| Native Currency | Euro (EUR) | ||
|
Financial Data - Bluepharma Genéricos
(31 Dec 2022) |
Revenue: - EBITDA: - Net Debt: - People: 19 |
||
| Date |
 |
||
| Country | |
||
| Geography |  |
||
| Subsector (Old TTR Sectors) |
|
||
| Type |
|
||
| Intel Grade |
|
||
| Source |
|
||
| Tags | |
Target
| Name |
|
||
| Subsector (Old TTR Sectors) |
|
||
| Primary Sector (TTRSC) |
30.01.03 Pharmaceutical R&D, Manufacturing & Distribution 30 Healthcare / 30.01 Biotechnology & Pharmaceuticals |
||
| Country |
|
||
| Website |
|
||
| Description |
|
Legend:
Verified: Confirmed as a party to an active or possible transaction.
Potential: Unconfirmed as a party to an active or possible transaction.
Retained: Confirmed as “Retained” with a general or specific mandate.
Prospect: Advisory “Prospect” in discussions with or pitching services to possible client.
Transactional data is continuously updated by the research team and therefore is subject to change.